Pharmaceutical Ingredients in Drinking Water: Overview of Occurrence and Significance of Human Exposure

被引:0
|
作者
Daughton, C. G. [1 ]
机构
[1] US EPA, Natl Exposure Res Lab, Las Vegas, NV 89119 USA
来源
CONTAMINANTS OF EMERGING CONCERN IN THE ENVIRONMENT: ECOLOGICAL AND HUMAN HEALTH CONSIDERATIONS | 2010年 / 1048卷
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; ENDOCRINE DISRUPTING COMPOUNDS; INDIRECT POTABLE REUSE; HEALTH-RISK ASSESSMENT; WASTE-WATER; LIQUID-CHROMATOGRAPHY; EMERGING CONTAMINANTS; MASS-SPECTROMETRY; GROUND-WATER;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A comprehensive examination is presented of the data published through 2009 on the active pharmaceutical ingredients (APIs) that have been reported in finished drinking water (FDW). A synoptic review reveals that quantitative occurrence data for FDW exists for 64 APIs and miscellaneous transformation products, reported in 48 publications. Significantly, however, for these 64 substances only 17 have quantitative data from more than two reports each; only 36 have corroborative data from a second study. Almost all of the available data has been published since the year 2000. The occurrence data are organized around the Anatomical Therapeutic Chemical (ATC) classification system. The top four ATC classes for which the most API data have been reported are: N, C, V, and M. APIs have been reported for 7 of the 14 main ATC classes; no API has been reported for ATC classes A, B, H, L, R, or S. Some emphasis is also placed on negative data - those APIs with either data of absence or absence of data. The six most frequently reported APIs in FDW (in descending order) are: carbamazepine, ibuprofen, sulfamethoxazole, clofibric acid, gemfibrozil, and iopromide. The six APIs with roughly the most consistent highest reported concentrations are: ibuprofen, triclosan, carbamazepine, phenazone, clofibric acid, and acetaminophen. With only one exception (ibuprofen and its methyl ester metabolite), no API exceeded a concentration of 1 ppb (1 mu g/L). Also covered are some of the reported transformation products and disinfection by-products unique to APIs. Some of the less-discussed aspects of the potential ramifications for human health are also included. A clearer picture is emerging as to the extent and scope of API occurrence in drinking water, some preliminary generalizations can be drawn, and a better sense is emerging of where future research should be directed.
引用
收藏
页码:9 / 68
页数:60
相关论文
共 50 条
  • [1] Active pharmaceutical ingredients in Malaysian drinking water: consumption, exposure, and human health risk
    Wee, Sze Yee
    Haron, Didi Erwandi Mohamad
    Aris, Ahmad Zaharin
    Yusoff, Fatimah Md
    Praveena, Sarva Mangala
    ENVIRONMENTAL GEOCHEMISTRY AND HEALTH, 2020, 42 (10) : 3247 - 3261
  • [2] Active pharmaceutical ingredients in Malaysian drinking water: consumption, exposure, and human health risk
    Sze Yee Wee
    Didi Erwandi Mohamad Haron
    Ahmad Zaharin Aris
    Fatimah Md. Yusoff
    Sarva Mangala Praveena
    Environmental Geochemistry and Health, 2020, 42 : 3247 - 3261
  • [3] OCCURRENCE AND SIGNIFICANCE OF ACTINOMYCETES IN DRINKING-WATER
    DOTT, W
    WASCHKODRANSMANN, D
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIE B-UMWELTHYGIENE KRANKENHAUSHYGIENE ARBEITSHYGIENE PRAVENTIVE MEDIZIN, 1981, 173 (3-4): : 217 - 232
  • [4] OCCURRENCE AND SIGNIFICANCE OF FUNGI IN DRINKING-WATER
    ROSENZWEIG, WD
    PIPES, WO
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 263 - ENVR
  • [5] Occurrence of pharmaceutical residues in drinking water: a systematic review
    Stefano Zanni
    Vincenzo Cammalleri
    Ludovica D’Agostino
    Carmela Protano
    Matteo Vitali
    Environmental Science and Pollution Research, 2025, 32 (16) : 10436 - 10463
  • [6] Occurrence and human exposure to bromate via drinking water, fruits and vegetables in Chile
    Raul, Calderon
    Kim, Un-Jung
    Kannan, Kurunthachalam
    CHEMOSPHERE, 2019, 228 : 444 - 450
  • [7] AEROMONADS IN DRINKING-WATER SUPPLIES - THEIR OCCURRENCE AND SIGNIFICANCE
    HOLMES, P
    NICOLLS, LM
    JOURNAL OF THE CHARTERED INSTITUTION OF WATER AND ENVIRONMENTAL MANAGEMENT, 1995, 9 (05): : 464 - 469
  • [8] Occurrence and potential human health risk of pharmaceutical residues in drinking water from Putrajaya (Malaysia)
    Praveena, Sarva Mangala
    Rashid, Maizatul Zahirah Mohd
    Nasir, Fauzan Adzima Mohd
    Yee, Wee Sze
    Aris, Ahmad Zaharin
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2019, 180 : 549 - 556
  • [9] Pharmaceutical residues in the aquatic environment and their significance for drinking water production
    Zwiener, C
    Gremm, TJ
    Frimmel, FH
    PHARMACEUTICALS IN THE ENVIRONMENT: SOURCES, FATE, EFFECTS, AND RISKS, 2001, : 81 - 89
  • [10] Exposure assessment: Sources and occurrence of pathogens in drinking water
    LeChevallier, MW
    MICROBIAL PATHOGENS AND DISINFECTION BY-PRODUCTS IN DRINKING WATER: HEALTH EFFECTS AND MANAGEMENT OF RISKS, 2000, : 67 - 88